US Stock MarketDetailed Quotes

NYMXF Nymox Pharmaceutical

Watchlist
  • 0.075
  • -0.075-49.93%
15min DelayClose Nov 29 13:00 ET
7.02MMarket Cap-751P/E (TTM)

Nymox Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.06%-4.06M
28.18%-897K
3.29%-1.26M
-158.38%-909K
76.52%-988K
47.00%-5.21M
44.46%-1.25M
56.47%-1.31M
181.86%1.56M
-57.62%-4.21M
Net income from continuing operations
-34.49%-8.84M
-296.64%-5.31M
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
133.58%1.34M
-108.53%-5.09M
Depreciation and amortization
-32.13%169K
-81.97%11K
-32.79%41K
-7.94%58K
-7.81%59K
-1.97%249K
-4.69%61K
-3.17%61K
0.00%63K
0.00%64K
Other non cash items
--440K
----
----
----
----
----
----
----
----
----
Change In working capital
65.86%821K
907.87%719K
-406.59%-279K
148.68%111K
-62.55%270K
453.57%495K
60.27%-89K
49.18%91K
-138.06%-228K
225.17%721K
-Change in receivables
-133.33%-1K
---4K
400.00%3K
--0
--0
-57.14%3K
--0
-133.33%-1K
--1K
-40.00%3K
-Change in inventory
----
----
----
----
--0
----
----
----
----
--0
-Change in prepaid assets
-531.03%-500K
-77.31%27K
-442.39%-499K
-72.82%28K
-300.00%-56K
544.44%116K
1,800.00%119K
22.03%-92K
119.15%103K
-114.58%-14K
-Change in payables and accrued expense
251.60%1.32M
434.62%696K
17.93%217K
125.00%83K
-55.46%326K
327.88%376K
3.70%-208K
4.55%184K
-160.14%-332K
208.12%732K
Cash from discontinued investing activities
Operating cash flow
22.06%-4.06M
28.18%-897K
3.29%-1.26M
-158.38%-909K
76.52%-988K
47.00%-5.21M
44.46%-1.25M
56.47%-1.31M
181.86%1.56M
-57.62%-4.21M
Investing cash flow
Cash flow from continuing investing activities
-3K
0
0
0
-3K
0
0
0
0
0
Net PPE purchase and sale
---3K
--0
--0
--0
---3K
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
---3K
--0
--0
--0
---3K
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-52.80%2.73M
1,813.46%891K
2,111.67%1.21M
-62.52%690K
-101.51%-61K
-17.98%5.78M
11.86%-52K
-1.69%-60K
-74.51%1.84M
6,848.33%4.05M
Net issuance payments of debt
788.65%1.58M
3,448.08%1.74M
-1,221.67%-793K
1,289.66%690K
-3.39%-61K
3.78%-229K
11.86%-52K
-1.69%-60K
3.33%-58K
1.67%-59K
Net common stock issuance
-80.86%1.15M
---850K
--2M
--0
--0
-17.52%6.01M
--0
--0
-73.93%1.9M
--4.11M
Cash from discontinued financing activities
Financing cash flow
-52.80%2.73M
1,813.46%891K
2,111.67%1.21M
-62.52%690K
-101.51%-61K
-17.98%5.78M
11.86%-52K
-1.69%-60K
-74.51%1.84M
6,848.33%4.05M
Net cash flow
Beginning cash position
-69.04%-1.4M
-97.19%76K
-96.76%132K
-47.77%351K
69.04%1.4M
77.01%-830K
-13.94%2.7M
-34.37%4.07M
-23.64%672K
-77.01%830K
Current changes in cash
332.64%1.33M
208.70%2.66M
95.90%-56K
-106.44%-219K
-565.82%-1.05M
-120.60%-573K
-175.29%-2.45M
55.34%-1.37M
-36.14%3.4M
94.21%-158K
End cash Position
95.01%-70K
95.01%-70K
-97.19%76K
-96.76%132K
-47.77%351K
-69.04%-1.4M
-69.04%-1.4M
-13.94%2.7M
-34.37%4.07M
-23.64%672K
Free cash flow
22.00%-4.06M
28.18%-897K
3.29%-1.26M
-158.38%-909K
76.44%-991K
47.03%-5.21M
44.56%-1.25M
56.47%-1.31M
181.86%1.56M
-57.51%-4.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.06%-4.06M28.18%-897K3.29%-1.26M-158.38%-909K76.52%-988K47.00%-5.21M44.46%-1.25M56.47%-1.31M181.86%1.56M-57.62%-4.21M
Net income from continuing operations -34.49%-8.84M-296.64%-5.31M30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M133.58%1.34M-108.53%-5.09M
Depreciation and amortization -32.13%169K-81.97%11K-32.79%41K-7.94%58K-7.81%59K-1.97%249K-4.69%61K-3.17%61K0.00%63K0.00%64K
Other non cash items --440K------------------------------------
Change In working capital 65.86%821K907.87%719K-406.59%-279K148.68%111K-62.55%270K453.57%495K60.27%-89K49.18%91K-138.06%-228K225.17%721K
-Change in receivables -133.33%-1K---4K400.00%3K--0--0-57.14%3K--0-133.33%-1K--1K-40.00%3K
-Change in inventory ------------------0------------------0
-Change in prepaid assets -531.03%-500K-77.31%27K-442.39%-499K-72.82%28K-300.00%-56K544.44%116K1,800.00%119K22.03%-92K119.15%103K-114.58%-14K
-Change in payables and accrued expense 251.60%1.32M434.62%696K17.93%217K125.00%83K-55.46%326K327.88%376K3.70%-208K4.55%184K-160.14%-332K208.12%732K
Cash from discontinued investing activities
Operating cash flow 22.06%-4.06M28.18%-897K3.29%-1.26M-158.38%-909K76.52%-988K47.00%-5.21M44.46%-1.25M56.47%-1.31M181.86%1.56M-57.62%-4.21M
Investing cash flow
Cash flow from continuing investing activities -3K000-3K00000
Net PPE purchase and sale ---3K--0--0--0---3K--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow ---3K--0--0--0---3K--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -52.80%2.73M1,813.46%891K2,111.67%1.21M-62.52%690K-101.51%-61K-17.98%5.78M11.86%-52K-1.69%-60K-74.51%1.84M6,848.33%4.05M
Net issuance payments of debt 788.65%1.58M3,448.08%1.74M-1,221.67%-793K1,289.66%690K-3.39%-61K3.78%-229K11.86%-52K-1.69%-60K3.33%-58K1.67%-59K
Net common stock issuance -80.86%1.15M---850K--2M--0--0-17.52%6.01M--0--0-73.93%1.9M--4.11M
Cash from discontinued financing activities
Financing cash flow -52.80%2.73M1,813.46%891K2,111.67%1.21M-62.52%690K-101.51%-61K-17.98%5.78M11.86%-52K-1.69%-60K-74.51%1.84M6,848.33%4.05M
Net cash flow
Beginning cash position -69.04%-1.4M-97.19%76K-96.76%132K-47.77%351K69.04%1.4M77.01%-830K-13.94%2.7M-34.37%4.07M-23.64%672K-77.01%830K
Current changes in cash 332.64%1.33M208.70%2.66M95.90%-56K-106.44%-219K-565.82%-1.05M-120.60%-573K-175.29%-2.45M55.34%-1.37M-36.14%3.4M94.21%-158K
End cash Position 95.01%-70K95.01%-70K-97.19%76K-96.76%132K-47.77%351K-69.04%-1.4M-69.04%-1.4M-13.94%2.7M-34.37%4.07M-23.64%672K
Free cash flow 22.00%-4.06M28.18%-897K3.29%-1.26M-158.38%-909K76.44%-991K47.03%-5.21M44.56%-1.25M56.47%-1.31M181.86%1.56M-57.51%-4.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data